Haemoglobin predicts total mortality in a general young and middle-aged male population. The Tromsø Study

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 66, Issue 7, 2006, Pages 567-576

  Skjelbakken, Tove ^a,b   Wilsgaard, T ^a   Forde O H ^a   Arnesen, E ^a   Lochen M L ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Body mass index; Epidemiology; Prospective; Smoking; Systolic blood pressure; Total cholesterol

Indexed keywords

CHOLESTEROL; HEMOGLOBIN;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMMUNITY ASSESSMENT; COMPARABLE WORTH; CONFIDENCE INTERVAL; CONTROLLED STUDY; EVALUATION; FOLLOW UP; GROUPS BY AGE; HUMAN; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MORTALITY; NORWAY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; BIOLOGICAL MARKERS; EPIDEMIOLOGIC STUDIES; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MORTALITY; NORWAY; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 33751085632     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510600863895     Document Type: Article

References (35)

1. Waters WE, Withey JL, Kilpatrick GS, Wood PH, Abernethy M. Ten-year haematological follow-up: mortality and haematological changes. Br Med J 1969;4:761-4.
2. Böttiger LE, Carlson LA. Risk factors for death for males and females. A study of the death pattern in the Stockholm prospective study. Acta Med Scand 1982;211:437-42.
3. Cullen KJ, Stenhouse NS, Wearne KL. Raised haemoglobin and risk of cardiovascular disease. Lancet 1981;2:1288-9.
4. Carlson LA, Böttiger LE. Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand 1985;218:207-11.
5. Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002;40:27-33.
6. Cullen K, Stenhouse NS, Wearne KL, Welborn TA. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia: 13-year study. J Chronic Dis 1983;36:371-7.
7. Salive ME, Cornoni HJ, Guralnik JM, Phillips CL, Wallace RB, Ostfeld AM, et al. Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status. J Am Geriatr Soc 1992;40: 489-96.
8. Bentley DP. Anaemia and chronic disease. Clin Haematol 1982;11:465-79.
9. Nordenberg D, Yip R, Binkin NJ. The effect of cigarette smoking on hemoglobin levels and anemia screening. JAMA 1990;264:1556-9.
10. Skjelbakken T, Langbakk B, Dahl IM, Løchen ML. Haemoglobin and anaemia in a gender perspective: The Tromsø Study. Eur J Haematol 2005;74:381-8.
11. Garn SM, Clark DC. Haemoglobin and fatness. Ecol Food Nutr 1975;4:131-3.
12. Böttiger LE, Carlson LA. Relation between serum cholesterol and triglyceride concentration and haemoglobin values in non-anaemic healthy persons. Br Med J 1972;3:731-3.
13. Shimakawa T, Bild DE. Relationship between hemoglobin and cardiovascular risk factors in young adults. J Clin Epidemiol 1993;46:1257-66.
14. Thelle DS, Førde OH, Try K, Lehmann EH. The Tromsø heart study. Methods and main results of the cross-sectional study. Acta Med Scand 1976;200:107-18.
15. Bønaa KH, Thelle DS. Association between blood pressure and serum lipids in a population. The Tromsø Study. Circulation 1991;83:1305-14.
16. Bønaa KH, Arnesen E. Association between heart rate and atherogenic blood lipid fractions in a population. The Tromsø Study. Circulation 1992;86:394-405.
17. International Committee for Standardization in Haematology. Recommendations and requirements for haemoglobinometry in human blood. Scand J Clin Lab Invest 1965;17:617-20.
18. Huang TC, Chen CP, Wefler V, Raftery A. A stable reagent for the Liebermann-Burchard reaction. Analytical Chemistry 1961;33:1405-7.
19. Tverdal A. A mortality follow-up of persons invited to a cardiovascular disease study in five areas in Norway. Oslo: National Health Screening Service; 1989.
20. Sorlie PD, Garcia-Palmieri MR, Costas R, Jr., Havlik RJ. Hematocrit and risk of coronary heart disease: the Puerto Rico Health Program. Am Heart J 1981;101:456-61.
21. Gagnon DR, Zhang TJ, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease - the Framingham study: a 34-year follow-up. Am Heart J 1994;127:674-82.
22. Brown DW, Giles WH, Croft JB. Hematocrit and the risk of coronary heart disease mortality. Am Heart J 2001;142:657-63.
23. Kannel WB, Gordon T, Wolf PA, McNamara P. Hemoglobin and the risk of cerebral infarction: the Framingham Study. Stroke 1972;3:409-20.
24. Erikssen G, Thaulow E, Sandvik L, Stormorken H, Erikssen J. Haematocrit: a predictor of cardiovascular mortality? J Intern Med 1993;234:493-9.
25. Abu-Zeid HA, Chapman JM. The relation between hemoglobin level and the risk for ischemic heart disease: a prospective study. J Chronic Dis 1976;29:395-403.
26. Ernst E, Matrai A. Abstention from chronic cigarette smoking normalizes blood rheology. Atherosclerosis 1987;64:75-7.
27. Koenig W, Sund M, Filipiak B, Doring A, Lowel H, Ernst E. Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992. Arterioscler Thromb Vasc Biol 1998;18:768-72.
28. Koenig W, Sund M, Lowel H, Doring A, Ernst E. Association between plasma viscosity and all-cause mortality: results from the MONICA-Augsburg Cohort Study 1984-92. Br J Haematol 2000;109:453-8.
29. Nestel P. Adjusting hemoglobin values in program surveys. Available at: http://inacg.ilsi.org/publications/. Washington, DC: INACG Secretariat; 2002.
30. WHO/UNICEF/UNO. Iron deficiency anaemia. Assessment, prevention, and control. A guide for programme managers. Geneva, World Health Organization; 2001.
31. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Techn Rep Ser; 1997.
32. Micozzi MS, Albanes D, Stevens RG. Relation of body size and composition to clinical biochemical and hematologic indices in US men and women. Am J Clin Nutr 1989;50:1276-81.
33. Koenig W, Sund M, Ernst E, Keil U, Rosenthal J, Hombach V. Association between plasma viscosity and blood pressure. Results from the MONICA-project Augsburg. Am J Hypertens 1991;4:529-36.
34. Njølstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 1996;93:450-6.
35. Njølstad I, Arnesen E. Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: a prospective analysis from the Finnmark Study. Arch Intern Med 1998;158:1326-32.